
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6016867
[patent_doc_number] => 20020103131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Prevention of diabetes by administration of GnRH antagonists'
[patent_app_type] => new
[patent_app_number] => 09/771434
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3193
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771434
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771434 | Prevention of diabetes by administration of GnRH antagonists | Jan 25, 2001 | Abandoned |
Array
(
[id] => 1175771
[patent_doc_number] => 06747005
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-08
[patent_title] => 'Assays, methods and means for modulating nuclear localization'
[patent_app_type] => B1
[patent_app_number] => 09/744469
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12222
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/747/06747005.pdf
[firstpage_image] =>[orig_patent_app_number] => 09744469
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/744469 | Assays, methods and means for modulating nuclear localization | Jan 24, 2001 | Issued |
Array
(
[id] => 7308900
[patent_doc_number] => 20040142429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides'
[patent_app_type] => new
[patent_app_number] => 09/768313
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3755
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142429.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768313
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768313 | Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides | Jan 24, 2001 | Abandoned |
Array
(
[id] => 7092529
[patent_doc_number] => 20010033878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Porphyrin containing lactic acid bacterial cells and use thereof'
[patent_app_type] => new
[patent_app_number] => 09/767680
[patent_app_country] => US
[patent_app_date] => 2001-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10150
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20010033878.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767680
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767680 | Porphyrin containing lactic acid bacterial cells and use thereof | Jan 23, 2001 | Abandoned |
Array
(
[id] => 7643744
[patent_doc_number] => 06429296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-08-06
[patent_title] => 'Complex of human growth hormone and zinc and use'
[patent_app_type] => B2
[patent_app_number] => 09/767144
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9959
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429296.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767144
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767144 | Complex of human growth hormone and zinc and use | Jan 22, 2001 | Issued |
| 09/744328 | Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix | Jan 22, 2001 | Abandoned |
Array
(
[id] => 5906108
[patent_doc_number] => 20020142414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Process for the preparation of protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/765287
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 35085
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142414.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765287 | Process for the preparation of protease inhibitors | Jan 21, 2001 | Abandoned |
Array
(
[id] => 6893984
[patent_doc_number] => 20010016350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins'
[patent_app_type] => new
[patent_app_number] => 09/766898
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27916
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766898
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766898 | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins | Jan 21, 2001 | Issued |
Array
(
[id] => 5951325
[patent_doc_number] => 20020006638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Methods for recombinant microbial production of fusion proteins and BPI-derived peptides'
[patent_app_type] => new
[patent_app_number] => 09/765527
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15395
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765527 | Methods for recombinant microbial production of fusion proteins and BPI-derived peptides | Jan 17, 2001 | Abandoned |
Array
(
[id] => 7092861
[patent_doc_number] => 20010034017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Process for the isolation and/or purification of a proteinaceous material'
[patent_app_type] => new
[patent_app_number] => 09/760379
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3070
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034017.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760379 | Process for the isolation and/or purification of a proteinaceous material | Jan 15, 2001 | Issued |
Array
(
[id] => 6880441
[patent_doc_number] => 20010031728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-18
[patent_title] => 'Aerothricin derivatives'
[patent_app_type] => new
[patent_app_number] => 09/760949
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8689
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20010031728.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760949 | Aerothricin derivatives | Jan 15, 2001 | Issued |
Array
(
[id] => 5845178
[patent_doc_number] => 20020132756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Encapsulated oil and fat products with free fatty acids'
[patent_app_type] => new
[patent_app_number] => 09/760971
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1662
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132756.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760971
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760971 | Encapsulated oil and fat products with free fatty acids | Jan 15, 2001 | Abandoned |
Array
(
[id] => 6896390
[patent_doc_number] => 20010027180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'GLP-2 formulations'
[patent_app_type] => new
[patent_app_number] => 09/750022
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6062
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027180.pdf
[firstpage_image] =>[orig_patent_app_number] => 09750022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/750022 | GLP-2 formulations | Dec 28, 2000 | Issued |
Array
(
[id] => 5923962
[patent_doc_number] => 20020115832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Methods for producing factor VIII proteins'
[patent_app_type] => new
[patent_app_number] => 09/752280
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4691
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115832.pdf
[firstpage_image] =>[orig_patent_app_number] => 09752280
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/752280 | Methods for producing factor VIII proteins | Dec 28, 2000 | Issued |
Array
(
[id] => 390180
[patent_doc_number] => 07300775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents'
[patent_app_type] => utility
[patent_app_number] => 09/751299
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27335
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300775.pdf
[firstpage_image] =>[orig_patent_app_number] => 09751299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/751299 | Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents | Dec 27, 2000 | Issued |
Array
(
[id] => 1271718
[patent_doc_number] => 06653461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-25
[patent_title] => 'Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis'
[patent_app_type] => B2
[patent_app_number] => 09/750876
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7035
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653461.pdf
[firstpage_image] =>[orig_patent_app_number] => 09750876
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/750876 | Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis | Dec 27, 2000 | Issued |
Array
(
[id] => 475308
[patent_doc_number] => 07226905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-05
[patent_title] => 'Process for the preparation of cyclosporin derivatives'
[patent_app_type] => utility
[patent_app_number] => 09/742008
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8883
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742008
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742008 | Process for the preparation of cyclosporin derivatives | Dec 21, 2000 | Issued |
Array
(
[id] => 6380994
[patent_doc_number] => 20020119916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Elemental nanoparticles of substantially water insoluble materials'
[patent_app_type] => new
[patent_app_number] => 09/748803
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3292
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119916.pdf
[firstpage_image] =>[orig_patent_app_number] => 09748803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/748803 | Method of making nanoparticles of substantially water insoluble materials | Dec 21, 2000 | Issued |
Array
(
[id] => 1014526
[patent_doc_number] => 06893868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => 'Homo-doubly labeled compositions for the detection of enzyme activity in biological samples'
[patent_app_type] => utility
[patent_app_number] => 09/747287
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28746
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/893/06893868.pdf
[firstpage_image] =>[orig_patent_app_number] => 09747287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/747287 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | Dec 21, 2000 | Issued |
Array
(
[id] => 6624347
[patent_doc_number] => 20020065394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Secreted proteins and polynucleotides encoding them'
[patent_app_type] => new
[patent_app_number] => 09/745763
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 82549
[patent_no_of_claims] => 264
[patent_no_of_ind_claims] => 201
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065394.pdf
[firstpage_image] =>[orig_patent_app_number] => 09745763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/745763 | Secreted proteins and polynucleotides encoding them | Dec 21, 2000 | Abandoned |